Biochemotherapy with interleukin-2 for metastatic melanoma: Long-term results in 100 patients.
David R. Minor
Consultant or Advisory Role - GlaxoSmithKline
Stock Ownership - Bristol-Myers Squibb (I)
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Mohammed Kashani-Sabet
No relevant relationships to disclose